Amrutanjan Health Care Limited

NSEI:AMRUTANJAN Rapporto sulle azioni

Cap. di mercato: ₹20.4b

Amrutanjan Health Care Performance dei guadagni passati

Il passato criteri di controllo 2/6

Amrutanjan Health Care ha registrato una crescita degli utili a un tasso medio annuo di 4.9%, mentre il settore Pharmaceuticals ha registrato utili in crescita a un tasso medio annuo di 13.6%. I ricavi sono stati in crescita a un tasso medio annuo di 9.6%. Il ritorno sul capitale proprio di Amrutanjan Health Care è 14.8% e ha margini netti di 10%.

Informazioni chiave

4.9%

Tasso di crescita degli utili

5.0%

Tasso di crescita dell'EPS

Pharmaceuticals Crescita del settore17.5%
Tasso di crescita dei ricavi9.6%
Rendimento del capitale proprio14.8%
Margine netto10.0%
Prossimo aggiornamento sui guadagni12 Nov 2024

Aggiornamenti sulle prestazioni recenti

We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

May 31
We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

Recent updates

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 17
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

May 31
We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

May 03
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Feb 12
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Sep 02
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Aug 05
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Feb 17
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Nov 08
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Aug 18
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 30
Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Apr 08
Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Mar 11
Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Feb 24
Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Feb 14
Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 12
Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Jan 30
Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Jan 17
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

Jan 04
Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

Dec 22
What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

Dec 09
How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Nov 26
If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Nov 14
Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Oct 28
Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

Oct 10
Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

Sep 22
I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

Sep 01
What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For

Aug 11
With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For

Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?

Jul 29
Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?

Ripartizione dei ricavi e delle spese

Come Amrutanjan Health Care guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.


Storia dei guadagni e delle entrate

NSEI:AMRUTANJAN Ricavi, spese e utili (INR Millions )
DataRicaviGuadagniSpese G+ASpese di R&S
30 Jun 244,2714261,0480
31 Mar 244,2144504840
31 Dec 233,9464403980
30 Sep 233,7533734610
30 Jun 233,8654329730
31 Mar 233,7983984930
31 Dec 223,8604185000
30 Sep 223,9905174940
30 Jun 223,9865881,0370
31 Mar 224,0596725050
31 Dec 213,9356271,2110
30 Sep 213,8296311,1590
30 Jun 213,6446689660
31 Mar 213,3306124970
31 Dec 202,9845897630
30 Sep 202,8114747770
30 Jun 202,6353228090
31 Mar 202,6172518340
31 Dec 192,8763148330
30 Sep 192,7512748040
30 Jun 192,6212577500
31 Mar 192,5352507560
31 Dec 182,4061587850
30 Sep 182,3351687620
30 Jun 182,2882017100
31 Mar 182,2032006710
31 Dec 172,2471657220
31 Mar 172,2402117100
31 Mar 161,8672065050
31 Mar 151,6661494680
31 Mar 141,4171245081

Guadagni di qualità: AMRUTANJAN ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di AMRUTANJAN (10%) sono inferiori rispetto allo scorso anno (11.2%).


Flusso di cassa libero e analisi degli utili


Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di AMRUTANJAN sono cresciuti del 4.9% all'anno negli ultimi 5 anni.

Accelerare la crescita: AMRUTANJAN ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: AMRUTANJAN ha avuto una crescita negativa degli utili ( -1.4% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Pharmaceuticals ( 19.1% ).


Rendimento del capitale proprio

ROE elevato: Il Return on Equity ( 14.8% ) di AMRUTANJAN è considerato basso.


Rendimento delle attività


Rendimento del capitale investito


Scoprire le aziende con forti performance passate